Literature DB >> 7494779

Carcinoid syndrome due to a malignant somatostatinoma.

O Ozbakir1, F Keleştimur, F Oztürk, E Sözüer, A Unal, T E Patiroğlu, K Güven.   

Abstract

Somatostatinoma is one of the rarest tumours of the endocrine pancreas. Cardinal manifestations of a somatostatinoma include gallstones, mild diabetes mellitus, steatorrhoea, diarrhoea and dyspepsia. Like any other pancreatic islet cell carcinoma, a somatostatinoma may also produce several different hormones such as adrenocorticotropic hormone, calcitonin, vasoactive intestinal polypeptide, pancreatic polypeptide, gastrin, insulin, and glucagon. In many cases, the clinical picture is dominated by the effect of these other hormones. We present a patient with somatostatinoma in which an immunocytochemical study of the specimens from pancreas and liver showed a weak positive reaction for gastrin besides a strong positive reaction for somatostatin. Interestingly, this patient also showed the signs of carcinoid syndrome which was successfully treated with octreotide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494779      PMCID: PMC2398332          DOI: 10.1136/pgmj.71.841.695

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

1.  Pancreatic somatostatinoma: histologic, clinical, and angiographic features.

Authors:  A J Gerlock; C A Muhletaler; S Halter; V Goncharenko
Journal:  AJR Am J Roentgenol       Date:  1979-11       Impact factor: 3.959

2.  Follow-up of a patient with somatostatinoma.

Authors:  G J Krejs; S M Collins; D McCarthy; R H Unger; J D Gardner
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

3.  Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.

Authors:  L K Kvols; C G Moertel; M J O'Connell; A J Schutt; J Rubin; R G Hahn
Journal:  N Engl J Med       Date:  1986-09-11       Impact factor: 91.245

4.  Somatostatinoma.

Authors:  R H Unger
Journal:  N Engl J Med       Date:  1977-04-28       Impact factor: 91.245

5.  Pancreatic islet cell carcinoma producing gastrin, ACTH, alpha-endorphin, somatostatin and calcitonin.

Authors:  S L Asa; K Kovacs; D W Killinger; N Marcon; M Platts
Journal:  Am J Gastroenterol       Date:  1980-07       Impact factor: 10.864

6.  "Somatostatinoma": a somatostatin-containing tumor of the endocrine pancreas.

Authors:  O P Ganda; G C Weir; J S Soeldner; M A Legg; W L Chick; Y C Patel; A M Ebeid; K H Gabbay; S Reichlin
Journal:  N Engl J Med       Date:  1977-04-28       Impact factor: 91.245

7.  Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.

Authors:  D Pipeleers; E Couturier; W Gepts; J Reynders; G Somers
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

8.  Pancreatic somatostatinoma. Clinical features and physiological implications.

Authors:  L I Larsson; M A Hirsch; J J Holst; S Ingemansson; C Kühl; S L Jensen; G Lundqvist; J F Rehfeld; T W Schwartz
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

  8 in total
  2 in total

1.  Two synchronous somatostatinomas of the duodenum and pancreatic head in one patient.

Authors:  Radoje B Colović; Slavko V Matić; Marjan T Micev; Nikica M Grubor; Henry Dushan Atkinson; Stojan M Latincić
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

2.  Clinicopathological Data and Treatment Modalities for Pancreatic Somatostatinomas.

Authors:  Aikaterini Mastoraki; Dimitrios Schizas; Eleni Papoutsi; Vasiliki Ntella; Prodromos Kanavidis; Athanasios Sioulas; Marina Tsoli; Georgios Charalampopoulos; Michail Vailas; Evangelos Felekouras
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.